quote:INXR (.0007) iFinix Corp. Successfully Launches the iFinix RealTime Information Platform
Tuesday, July 17 2007 11:12 AM, EST Market Wire "US Press Releases " JAMAICA , NY -- (MARKETWIRE) -- 07/17/07 -- iFinix Corp. (PINKSHEETS: INXR) announced that the launch of the iFinix RealTime Information Platform went off successfully. The company also reported that it has established an automatic system update so that computer glitches that are discovered are corrected as they are reported. Moreover, each subscriber's system automatically receives the corrections as they are made. The company also announced that nearly 2,000 subscribers have signed up to participate in the program. iFinix Chairman Drew Budhu said, "The retail investment community has enthusiastically welcomed the iFinix RealTime Information Platform. The warm reception is very gratifying. Although we found some bugs, they have been corrected and users are receiving automatic updates correcting any system errors." Budhu noted that iFinix is still offering new subscribers a one-month introductory subscription for $20 . (The subscription does not include Exchange fees, which are extra depending on the market.) Subscribers can sign up using either a credit card or PayPal by visiting it secure site, https://www.ifinix.com/subscription/. Shareholders of record as of June 17 are entitled to a free three-month subscription; they can sign up by calling 516-504-3981, ext. 301. Those traders, who sign up for the four-month introductory offer of $20 a month, will be automatically renewed unless they subscriber notifies iFinix. The regular monthly charge is $60 and it will be billed to their credit cards. The iFinix RealTime Information Platform provides pricing and volume information to microcap traders and broker/dealers of microcap stocks equal to that available on blue-chip stocks. Its price reporting is precise to the sixth decimal point -- two decimal points greater than its competition -- a difference that is financially significant to frequent traders. About iFinix Corp. iFinix is a diversified information technology services and solutions company with expertise in systems integration, outsourcing, infrastructure and server technology. iFinix has established a product line that delivers financial and business information with streaming, real-time market data, news and analytics to professionals and active individual investors. The company's suite of products includes iFinix RealTime, iFinix Trader and eFinix. Visit http://www.iFinix.com Legal Notice Regarding Forward-Looking Statements: Safe Harbor: This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of iFinix Corporation to be materially different from the statements made herein. Contact: iFinix Corporation Investor Relations 516-504-3981 x301
posted
LLEG .0007 Laidlaw Engages The Babcock & Wilcox Company to Work on Boiler Conversion to Biomass Fuel for Berlin, NH Project Jul 17, 2007 11:19:00 AM Copyright Business Wire 2007
NEW YORK--(BUSINESS WIRE)--
Laidlaw Energy Group, Inc. (Ticker Symbol "LLEG") announced today that its affiliate, Laidlaw Berlin, LLC, has entered into an exclusive arrangement with The Babcock & Wilcox Company to provide its services in connection with the conversion of a Babcock & Wilcox boiler located in Berlin, New Hampshire to biomass fuel. The boiler is located at the former Fraser Paper Mill which Laidlaw has proposed converting to a state-of-the-art 60 - 70 megawatt biomass-energy facility. The large Babcock & Wilcox recovery boiler was installed at the mill in 1993 at a cost of nearly $100 million and is believed to be highly suitable to conversion for biomass-energy purposes. Babcock & Wilcox has successfully completed several conversions of similar boilers to biomass fuel in recent the past.
The first stage of the engagement will be for Babcock & Wilcox to conduct a thorough engineering review in order to confirm the capabilities of the boiler and define the work that will be needed to complete the conversion. Once this is completed the parties expect to enter into a definitive agreement pursuant to which Babcock & Wilcox will perform such work.
Commenting on the engagement of Babcock & Wilcox, Laidlaw Energy President & CEO Michael B. Bartoszek stated, "We are happy to have B&W on board for the exciting project. We had discussions with several different boiler companies about this engagement, but at the end of the day we felt most comfortable with B&W's overall capabilities, including their financial resources, prior successful track record with this type of project, and the fact that they are the original manufacturer of this boiler and are highly familiar with it."
The Berlin biomass-energy facility is currently expected to commence operations in late 2008 or early 2009.
Posts: 3255 | From: Los Angeles California | Registered: Jan 2006
| IP: Logged |
posted
they gobbled my .0029 on ISBL like it was a friggin Junior Mint- was in at .0016.
Posts: 949 | From: Little Rock, AR | Registered: Dec 2005
| IP: Logged |
quote:Originally posted by bilgert: ISBL on the move
July 17, 2007 - 10:32 AM EST
Ise Blu Equity Corp. Signs Letter of Intent for the Acquisition of One Media One Ise Blu Equity Corp. (PINKSHEETS: ISBL) announced today that it has signed a Letter of Intent for the acquisition of One Media One, a new media company that offers entertainment, marketing and new media services.
“We are extremely pleased to add One Media One and its celebrity President Doctor Dre to the Ise Blu Equity family. Doctor Dre is best known for his groundbreaking Radio programs on Hot 97 and Power 1051 in New York. Doctor Dre is world renowned for the extremely popular and long running MTV powerhouse, 'YO MTV RAPS TODAY.' Doctor Dre starred in the hit New Line film, 'Who’s the Man' that can currently be seen on HBO, Showtime and various other cable networks. Our plans are to begin a move towards the OTCBB and secure funding for additional acquisitions as well as grow One Media One and all its future endeavors. We look for a substantial increase in other revenues and feel that it will also increase of our operations profitability," stated Norman Birmingham, company President.
Once the purchase agreement is completed the company will release detailed information outlining company growth plans and an interview with Doctor Dre as well as a growth timeline. The purchase agreement is required to be signed on or before July 27, 2007.
About Ise Blu Equity Corp.
Ise Blu Equity Corp., a Nevada corporation, is a holding company that specializes in investments from the Consumer Goods, Entertainment and Technology sectors.
"Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release that are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause results to differ materially from those expressed in the forward-looking statements, including but not limited to, certain delays and risks detailed from time to time in the company's filings with the Securities and Exchange Commission."
Ise Blu Equity Corp. Investor relations: Norman Birmingham, 410-309-5960 info*isebluequitycorp.com Info site: http://www.isebluequitycorp.com/
-------------------- #1 Rule: Protect your capital! #2 Rule: Never fall for the BS on the boards! Posts: 8890 | Registered: Jan 2006
| IP: Logged |
posted
ACE rememeber when Gilead got approved before ENCY and Gilead wasn't supposed to hear from the FDA until 3 days after ENCY's date...well the decision here is no where to be found, companies love to release GOOD news the second they get it, and FDA has not come forward with a statement. Approvable-if is likely, and I'll cover my $5.33 short at $3.00-$3.25, if this gets a straight out rejection this baby is shot! Wish I had options enabled, I'd be buying puts like crazy.
-------------------- Disclaimer: Not accountable for anything I say Posts: 6266 | Registered: Jun 2004
| IP: Logged |
posted
GEGP getting massive volume. Could be getting front loaded...Kinda peculiar that most of the volume is at .0001. But WNSH was the same way.
A very light rumor on Ihub that some news might come out near the end of the month. But Ihub rumors are like a$$holes: everybody'd got'em. but most of 'em stink...
Posts: 949 | From: Little Rock, AR | Registered: Dec 2005
| IP: Logged |
posted
NRMX approvable if letter read the bold from an analyst persepective.
Ms. Terrisse-Rulleau is also pushing back her assumptions on potential partnerships until after European Phase 3 trial data is released, expected in 2008.
She slashed her target price on Neurochem shares to $5.50 from $11.50 and lowered her rating to “sell” from “hold.” The stock is hovering below the $7 level these days, after falling from nearly $30 in December 2006.
But of the $5.50 in value she assigns to each Neurochem share, only 86¢ comes from Alzhemed. Along with its net cash position of 51¢ per share, the other $4.10 in value comes from another drug, Kiacta. The company hopes it will be able to treat a disease associated with chronic inflammatory diseases such as rheumatoid arthritis and Crohn’s. Ms. Terrisse-Rulleau is confident in the FDA outcome for this drug, which is due in the middle of July.
-------------------- Disclaimer: Not accountable for anything I say Posts: 6266 | Registered: Jun 2004
| IP: Logged |
Topic Closed
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
